These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 17510386)

  • 1. Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers.
    Pyeon D; Newton MA; Lambert PF; den Boon JA; Sengupta S; Marsit CJ; Woodworth CD; Connor JP; Haugen TH; Smith EM; Kelsey KT; Turek LP; Ahlquist P
    Cancer Res; 2007 May; 67(10):4605-19. PubMed ID: 17510386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of human leukocyte antigen associations in human papillomavirus-positive and -negative head and neck cancer: Comparison with cervical cancer.
    Ekanayake Weeramange C; Shu D; Tang KD; Batra J; Ladwa R; Kenny L; Vasani S; Frazer IH; Dolcetti R; Ellis JJ; Sturm RA; Leo P; Punyadeera C
    Cancer; 2022 May; 128(10):1937-1947. PubMed ID: 35176174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus type 16 (HPV-16) genomes integrated in head and neck cancers and in HPV-16-immortalized human keratinocyte clones express chimeric virus-cell mRNAs similar to those found in cervical cancers.
    Lace MJ; Anson JR; Klussmann JP; Wang DH; Smith EM; Haugen TH; Turek LP
    J Virol; 2011 Feb; 85(4):1645-54. PubMed ID: 21123375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the methylation patterns in human papillomavirus type 16 viral DNA in head and neck cancers.
    Park IS; Chang X; Loyo M; Wu G; Chuang A; Kim MS; Chae YK; Lyford-Pike S; Westra WH; Saunders JR; Sidransky D; Pai SI
    Cancer Prev Res (Phila); 2011 Feb; 4(2):207-17. PubMed ID: 21292634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and Complete Validation of Prognostic Gene Signatures for Human Papillomavirus-Associated Cancers: Integrated Approach Covering Different Anatomical Locations.
    Kwon EJ; Ha M; Jang JY; Kim YH
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33361419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of therapeutic sensitivity by human papillomavirus.
    Swick AD; Chatterjee A; De Costa AM; Kimple RJ
    Radiother Oncol; 2015 Sep; 116(3):342-5. PubMed ID: 26364887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus and human papillomavirus infections and genotype distribution in head and neck cancers.
    Deng Z; Uehara T; Maeda H; Hasegawa M; Matayoshi S; Kiyuna A; Agena S; Pan X; Zhang C; Yamashita Y; Xie M; Suzuki M
    PLoS One; 2014; 9(11):e113702. PubMed ID: 25405488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
    Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
    Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.
    Braakhuis BJ; Snijders PJ; Keune WJ; Meijer CJ; Ruijter-Schippers HJ; Leemans CR; Brakenhoff RH
    J Natl Cancer Inst; 2004 Jul; 96(13):998-1006. PubMed ID: 15240783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-18a targeting of the STK4/MST1 tumour suppressor is necessary for transformation in HPV positive cervical cancer.
    Morgan EL; Patterson MR; Ryder EL; Lee SY; Wasson CW; Harper KL; Li Y; Griffin S; Blair GE; Whitehouse A; Macdonald A
    PLoS Pathog; 2020 Jun; 16(6):e1008624. PubMed ID: 32555725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptome signature of irreversible senescence in human papillomavirus-positive cervical cancer cells.
    Wells SI; Aronow BJ; Wise TM; Williams SS; Couget JA; Howley PM
    Proc Natl Acad Sci U S A; 2003 Jun; 100(12):7093-8. PubMed ID: 12756294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus-mediated transfer of HPV 16 E6/E7 antisense RNA combined with cisplatin inhibits cellular growth and induces apoptosis in HPV-positive head and neck cancer cells.
    Kojima Y; Otsuki N; Kubo M; Kitamoto J; Takata E; Saito H; Kosaka K; Morishita N; Uehara N; Shirakawa T; Nibu KI
    Cancer Gene Ther; 2018 Oct; 25(9-10):274-283. PubMed ID: 29795305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
    Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
    Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical status and expression of HPV genes in cervical cancers.
    Park JS; Hwang ES; Park SN; Ahn HK; Um SJ; Kim CJ; Kim SJ; Namkoong SE
    Gynecol Oncol; 1997 Apr; 65(1):121-9. PubMed ID: 9103401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation-enhanced expression of E6/E7 transforming oncogenes of human papillomavirus-16 in human cervical carcinoma.
    Santin AD; Hermonat PL; Ravaggi A; Chiriva-Internati M; Pecorelli S; Parham GP
    Cancer; 1998 Dec; 83(11):2346-52. PubMed ID: 9840534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus E7 binds Oct4 and regulates its activity in HPV-associated cervical cancers.
    Panayiotou T; Michael S; Zaravinos A; Demirag E; Achilleos C; Strati K
    PLoS Pathog; 2020 Apr; 16(4):e1008468. PubMed ID: 32298395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison Between HPV DNA Testing and HPV E6/E7 MRNA Testing in Women with Squamous Cell Abnormalities of the Uterine Cervix.
    Dabeski D; Duvlis S; Basheska N; Antovska V; Stojovski M; Trajanova M; Dimitrov G; Dabeski A; Gureva-Gjorgievska N
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2019 May; 40(1):51-58. PubMed ID: 31152639
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Cao CH; Liu R; Lin XR; Luo JQ; Cao LJ; Zhang QJ; Lin SR; Geng L; Sun ZY; Ye SK; Yu ZY; Shi Y; Xia X
    Int J Biol Sci; 2021; 17(7):1744-1756. PubMed ID: 33994859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological and clinical aspects of HPV-related cancers.
    Szymonowicz KA; Chen J
    Cancer Biol Med; 2020 Nov; 17(4):864-878. PubMed ID: 33299640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.